| Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive … E Giné, A Martinez, N Villamor, A López-Guillermo, M Camos, D Martinez, ... Haematologica 95 (9), 1526, 2010 | 215 | 2010 |
| Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients A Martínez-Trillos, A Gaya, M Maffioli, E Arellano-Rodrigo, X Calvo, ... Annals of hematology 89, 1233-1237, 2010 | 212 | 2010 |
| Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition M Granell, X Calvo, A Garcia-Guiñón, L Escoda, E Abella, CM Martínez, ... Haematologica 102 (6), 1099, 2017 | 117 | 2017 |
| Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia P Abrisqueta, N Villamor, MJ Terol, E González-Barca, M González, ... Blood, The Journal of the American Society of Hematology 122 (24), 3951-3959, 2013 | 81 | 2013 |
| Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale S Bonanad, J De la Rubia, M Gironella, EP Persona, B González, ... Journal of geriatric oncology 6 (5), 353-361, 2015 | 79 | 2015 |
| Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS A Kündgen, M Nomdedeu, H Tuechler, G Garcia-Manero, RS Komrokji, ... Leukemia 35 (3), 835-849, 2021 | 69 | 2021 |
| Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression C Fernandez de Larrea, I Isola, A Pereira, MT Cibeira, L Magnano, ... Leukemia 32 (6), 1427-1434, 2018 | 65 | 2018 |
| Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features X Calvo, N Garcia-Gisbert, I Parraga, J Gibert, L Florensa, ... Blood Advances 4 (20), 5285-5296, 2020 | 34 | 2020 |
| High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndrome X Calvo, M Nomdedeu, A Navarro, R Tejero, D Costa, C Muñoz, A Pereira, ... Leukemia research 38 (8), 874-881, 2014 | 30 | 2014 |
| Optical Genome Mapping: A promising new tool to assess genomic complexity in chronic lymphocytic leukemia (CLL) A Puiggros, S Ramos-Campoy, J Kamaso, M de la Rosa, M Salido, ... Cancers 14 (14), 3376, 2022 | 29 | 2022 |
| Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL G Blanco, A Vardi, A Puiggros, A Gómez-Llonín, M Muro, ... Oncoimmunology 7 (6), e1432328, 2018 | 29 | 2018 |
| Loss of the immune checkpoint CD85j/LILRB1 on malignant plasma cells contributes to immune escape in multiple myeloma E Lozano, T Díaz, MP Mena, G Suñe, X Calvo, M Calderón, L Pérez-Amill, ... The Journal of Immunology 200 (8), 2581-2591, 2018 | 25 | 2018 |
| Considering bone marrow blasts from nonerythroid cellularity improves the prognostic evaluation of myelodysplastic syndromes L Arenillas, X Calvo, E Luño, L Senent, E Alonso, F Ramos, MT Ardanaz, ... Journal of Clinical Oncology 34 (27), 3284-3292, 2016 | 23 | 2016 |
| Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma C Recasens-Zorzo, T Cardesa-Salzmann, P Petazzi, L Ros-Blanco, ... haematologica 104 (4), 778, 2019 | 22 | 2019 |
| Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients S Ramos-Campoy, A Puiggros, S Beà, S Bougeon, MJ Larráyoz, D Costa, ... Haematologica 107 (3), 593, 2022 | 21 | 2022 |
| Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific … X Calvo, M Nomdedeu, R Santacruz, N Martínez, D Costa, A Pereira, ... Leukemia research 39 (11), 1146-1153, 2015 | 21 | 2015 |
| LMO2-negative expression predicts the presence of MYC translocations in aggressive B-cell lymphomas L Colomo, I Vazquez, N Papaleo, B Espinet, A Ferrer, C Franco, ... The American Journal of Surgical Pathology 41 (7), 877-886, 2017 | 20 | 2017 |
| Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group M Nomdedeu, A Pereira, X Calvo, J Colomer, F Sole, A Arias, C Gomez, ... Leukemia research 63, 85-89, 2017 | 19 | 2017 |
| Excess mortality in the myelodysplastic syndromes M Nomdedeu, A Pereira, F Ramos, D Valcárcel, D Costa, M Arnan, ... American Journal of Hematology 92 (2), 149-154, 2017 | 19 | 2017 |
| Serial intestinal endoscopic examinations of patients with persistent diarrhea after allo-SCT C Martínez, M Rosales, X Calvo, M Cuatrecasas, L Rodriguez-Carunchio, ... Bone marrow transplantation 47 (5), 694-699, 2012 | 18 | 2012 |
